Baguio, Francisco C.

HRN: 01-18-90  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/28/2022
CEFTAZIDIME 1GM (VIAL)
12/28/2022
01/04/2023
IV
1gram
Q8hrs
CAP MR With Presumptive
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: